It got derailed by the space industrial complex.
Category Archives: Technology and Society
Tomorrow’s Falcon Launch
…has been scrubbed, due to a failed static-fire test today. Seems to be an umbilical problem.
Maybe next week.
[Update late morning]
Here‘s the full story. As as often the case, it’s a range constraint. I’m sure that’s one of the big motivations to go to Texas. I recall seeing Gwynne wandering the hall at an AIAA conference about eight years ago (when they were getting screwed over at Vandenberg) muttering, “I hate ranges, I hate ranges.”
Apollo And The Pyramids
An analysis from Randall Munroe.
Launching A Space Start Up
Is now the time?
It seems like a very promising future, with a lot of converging technologies and trends.
An Anti-Aging Hormone
…that could make you smarter?
Heck, I’d be happy with the anti-aging part myself. Though I have a commenter or two that could stand to be smarter.
High-Speed Rail
From Beijing to CONUS? Under the Bering Strait?
I don’t think so.
Rocket Science Airlines
I have no comment.
3-D Printing And Spaceflight
Ten ways it could revolutionize it.
I really think we are on the verge of the most exciting era for human spaceflight since the sixties.
The New Crew Systems
A story on Dragon, CST and Dreamchaser at the Daily Mail.
Cancer
Have they really found a cure?
…the developments at Penn point, tantalizingly, to something more, something that would rank among the great milestones in the history of mankind: a true cure. Of 25 children and 5 adults with Emily’s disease, ALL, 27 had a complete remission, in which cancer becomes undetectable.“
It’s a stunning breakthrough,” says Sally Church, of drug development advisor Icarus Consultants. Says Crystal Mackall, who is developing similar treatments at the National Cancer Institute: “It really is a revolution. This is going to open the door for all sorts of cell-based and gene therapy for all kinds of disease because it’s going to demonstrate that it’s economically viable.”
Also:
“I’ve told the team that resources are not an issue. Speed is the issue,” says Novartis Chief Executive Joseph Jimenez, 54. “I want to hear what it takes to run this phase III trial and to get this to market. You’re talking about patients who are about to die. The pain of having to turn patients away is such that we are going as fast as we can and not letting resources get in the way.”
Yes. Faster please.